Cite
HARVARD Citation
Reveille, J. et al. (n.d.). AB0692 Effects of intravenous golimumab on patient-reported outcomes in active ankylosing spondylitis: 28-week results of the phase III go-alive trial. Annals of the rheumatic diseases. pp. 1295-1296. [Online].